Characterisation of P2X receptors expressed in rat pulmonary arteries

European Journal of Pharmacology

Volumn 649, Issue 1-3, 2010, Pages 342-348

  Syed, Nawazish I Husain ^a,b   Tengah, Asrin ^a,c   Paul, Andrew ^a   Kennedy, Charles ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b UNIVERSITY OF THE PUNJAB   (Pakistan)

^c UNIVERSITI BRUNEI DARUSSALAM   (Brunei Darussalam)

Author keywords

P2X receptor; Pulmonary artery; Smooth muscle; Vasoconstriction

Indexed keywords

4,4',4,4 [CARBONYLBIS[IMINO 5,1,3 BENZENETRIYLBIS(CARBONYLIMINO)]]TETRAKIS BENZENE 1,3 DISULFONIC ACID; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; MESSENGER RNA; NF 449; PURINERGIC P2X RECEPTOR; PURINERGIC P2X1 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; SURAMIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTICLE; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DESENSITIZATION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; GENE EXPRESSION; IMMUNOREACTIVITY; LUNG ARTERY PRESSURE; MALE; MYOGRAPHY; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PULMONARY ARTERY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; STAINING; TISSUE DISTRIBUTION;

ANIMALS; DOWN-REGULATION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LUNG; MALE; MUSCLE, SMOOTH, VASCULAR; OSMOLAR CONCENTRATION; PROTEIN SUBUNITS; PULMONARY ARTERY; PURINERGIC P2X RECEPTOR AGONISTS; PURINERGIC P2X RECEPTOR ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2X; RECEPTORS, PURINERGIC P2X1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASOCONSTRICTOR AGENTS;

EID: 78049293283     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.09.041     Document Type: Article

References (43)

1. Abbracchio M.P., Burnstock G., Boeynaems J.M., Barnard E.A., Boyer J.L., Kennedy C., Knight G.E., Fumagalli M., Gachet C., Jacobson K.A., Weisman G.A. International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol. Rev. 2006, 58:281-341.
2. Adnot S., Raffestin B., Eddahibi S., Braquet P., Chabrier P.E. Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J. Clin. Invest. 1991, 87:155-162.
3. Baek E.B., Yoo H.Y., Park S.J., Kim H.S., Kim S.D., Earm Y.E., Kim S.J. Luminal ATP-induced contraction of rabbit pulmonary arteries and role of purinoceptors in the regulation of pulmonary arterial pressure. Pflugers Arch. 2008, 457:281-291.
4. Barnes P.J., Liu S.F. Regulation of pulmonary vascular tone. Pharmacol. Rev. 1995, 47:87-131.
5. Brändle U., Spielmanns P., Osteroth R., Sim J., Surprenant A., Buell G., Ruppersberg J.P., Plinkert P.K., Zenner H.P., Glowatzki E. Desensitization of the P2X(2) receptor controlled by alternative splicing. FEBS Lett. 1997, 404:294-298.
6. Braun K., Rettinger J., Ganso M., Kassack M., Hildebrandt C., Ullmann H., Nickel P., Schmalzing G., Lambrecht G. NF449: a subnanomolar potency antagonist at recombinant rat P2X1 receptors. Naunyn Schmiedebergs Arch. Pharmacol. 2001, 364:285-290.
7. Brown S.G., Townsend-Nicholson A., Jacobson K.A., Burnstock G., King B.F. Heteromultimeric P2X(1/2) receptors show a novel sensitivity to extracellular pH. J. Pharmacol. Exp. Ther. 2002, 300:673-680.
8. Burnstock G., Kennedy C. Is there a basis for distinguishing two types of P2-purinoceptor?. Gen. Pharmacol. 1985, 16:433-440.
9. Burnstock G., Kennedy C. A dual function for adenosine triphosphate in the regulation of vascular tone: excitatory cotransmitter with noradrenaline from perivascular nerves and locally released inhibitory intravascular agent. Circ. Res. 1986, 58:319-330.
10. Burnstock G., Knight G.E. Cellular distribution and functions of P2 receptor subtypes in different systems. Int. Rev. Cytol. 2004, 240:31-304.
11. Bushell T.J., Plevin R., Cobb S., Irving A.J. Characterization of proteinase-activated receptor 2 signalling and expression in rat hippocampal neurons and astrocytes. Neuropharmacology 2006, 50:714-725.
12. Chootip K., Ness K., Wang J., Gurney A.M., Kennedy C. Regional variation in P2 receptor expression in the rat pulmonary arterial circulation. Br. J. Pharmacol. 2002, 137:637-646.
13. Chootip K., Gurney A.M., Kennedy C. Evidence for multiple P2Y receptors coupled to calcium-dependent, chloride channels in smooth muscle cells of the rat pulmonary artery. Respir. Res. 2005, 26:124.
14. Dinh-Xuan A.T., Higenbottam T.W., Clelland C.A., Pepke-Zaba J., Cremona G., Butt A.Y., Large S.R., Wells F.C., Wallwork J. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N Engl J. Med. 1991, 324:1539-1547.
15. Erlinge D., Burnstock G. P2 receptors in cardiovascular regulation and disease. PUSI 2008, 4:1-20.
16. Evans R.J., Kennedy C. Characterization of P2-purinoceptors in the smooth muscle of the rat tail artery: a comparison between contractile and electrophysiological responses. Br. J. Pharmacol. 1994, 113:853-860.
17. Gurney A.M., Osipenko O.N., MacMillan D., McFarlane R.J., Tate R.J., Kempsill F.E.J. Two-pore domain K channel, TASK-1, in pulmonary artery smooth muscle cells. Cir. Res. 2003, 93:957-964.
18. Haines W.R., Torres G.E., Voigt M.M., Egan T.M. Properties of the novel ATP-gated ionotropic receptor composed of the P2X(1) and P2X(5) isoforms. Mol. Pharmacol. 1999, 56:720-727.
19. Hansen M.A., Dutton J.L., Balcar V.J., Barden J.A., Bennett M.R. P2X (purinergic) receptor distributions in rat blood vessels. J. Auton. Nerv. Syst. 1999, 75:147-155.
20. Hartley S.A., Kato K., Salter K.J., Kozlowski R.Z. Functional evidence for a novel suramin-insensitive pyrimidine receptor in rat small pulmonary arteries. Circ. Res. 1998, 83:940-946.
21. Hassėssian H., Burnstock G. Interacting roles of nitric oxide and ATP in the pulmonary circulation of the rat. Br. J. Pharmacol. 1995, 114:846-850.
22. Hülsmann M., Nickel P., Kassack M., Schmalzing G., Lambrecht G., Markwardt F. NF449, a novel picomolar potency antagonist at human P2X1 receptors. Eur. J. Pharmacol. 2003, 470:1-7.
23. Jarvis M.F., Khakh B.S. ATP-gated P2X cation-channels. Neuropharm. 2009, 56:208-215.
24. Khakh B.S., Burnstock G., Kennedy C., King B.F., North R.A., Seguela P., Voigt M., Humphrey P.P. International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol. Rev. 2001, 53:107-118.
25. Koshimizu T., Tomic M., Van Goor F., Stojilkovic S.S. Functional role of alternative splicing in pituitary P2X2 receptor-channel activation and desensitization. Mol. Endocrinol. 1998, 12:901-913.
26. Lê K.T., Babinski K., Séguéla P. Central P2X4 and P2X6 channel subunits coassemble into a novel heteromeric ATP receptor. J. Neurosci. 1998, 18:7152-7159.
27. Lewis C.J., Evans R.J. P2X receptor immunoreactivity in different arteries from the femoral, pulmonary, cerebral, coronary and renal circulations. J. Vasc. Res. 2001, 38:332-340.
28. Liu S.F., McCormack D.G., Evans T.W., Barnes P.J. Characterization and distribution of P2-purinoceptor subtypes in rat pulmonary vessels. J. Pharmacol. Exp. Ther. 1989, 251:1204-1210.
29. Liu S.F., McCormack D.G., Evans T.W., Barnes P.J. Evidence for two P2-purinoceptor subtypes in human small pulmonary arteries. Br. J. Pharmacol. 1989, 98:1014-1020.
30. Lommatzsch M., Cicko S., Müller T., Lucattelli M., Bratke K., Stoll P., Grimm M., Dürk T., Zissel G., Ferrari D., Di Virgilio F., Sorichter S., Lungarella G., Virchow J.C., Idzko M. Extracellular adenosine triphosphate and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2010, 181:928-934.
31. Mam V., Tanbe A.F., Vitali S.H., Arons E., Christou H.A., Khalil R.A. Impaired vasoconstriction and nitric oxide-mediated relaxation in pulmonary arteries of hypoxia- and monocrotaline-induced pulmonary hypertensive rats. J. Pharmacol. Exp. Ther. 2010, 332:455-462.
32. McCormack D.G., Barnes P.J., Evans T.W. Purinoceptors in the pulmonary circulation of the rat and their role in hypoxic vasoconstriction. Br. J. Pharmacol. 1989, 98:367-372.
33. 2+ entry in intrapulmonary artery smooth muscle cells. Eur. J. Pharmacol. 2008, 584:10-20.
34. McLaren G.J., Burke K.S., Buchanan K.J., Sneddon P., Kennedy C. Evidence that ATP acts at two sites to evoke contraction in the rat isolated tail artery. Br. J. Pharmacol. 1998, 124:5-12.
35. 7 subunit-like immunoreactivity in the nucleus of visceral smooth muscle cells of the guinea-pig. Autonom. Nerv. Sys. 2003, 106:103-109.
36. Nicke A., Kerschensteiner D., Soto F. Biochemical and functional evidence for heteromeric assembly of P2X1 and P2X4 subunits. J. Neurochem. 2005, 92:925-933.
37. Rettinger J., Braun K., Hochmann H., Kassack M.U., Ullmann H., Nickel P., Schmalzing G., Lambrecht G. Profiling at recombinant homomeric and heteromeric rat P2X receptors identifies the suramin analogue NF449 as a highly potent P2X1 receptor antagonist. Neuropharmacol. 2005, 48:461-468.
38. Rubino A., Burnstock G. Evidence for a P2-purinoceptor mediating vasoconstriction by UTP, ATP and related nucleotides in the isolated pulmonary vascular bed of the rat. Br. J. Pharmacol. 1996, 118:1415-1420.
39. Rubino A., Ziabary L., Burnstock G. Regulation of vascular tone by UTP and UDP in isolated intrapulmonary arteries. Eur. J. Pharmacol. 1999, 370:139-143.
40. Simon J., Kidd E.J., Smith F.M., Chessell I.P., Murrell-Lagnado R., Humphrey P.P.A., Barnard E.A. Localization and functional expression of splice variants of the P2X2 receptor. Mol. Pharmacol. 1997, 52:237-248.
41. Sprague R.S., Ellsworth M.L., Stephenson A.H., Lonigro A.J. ATP: the red blood cell link to NO and local control of the pulmonary circulation. Am. J. Physiol. 1996, 271:H2717-H2722.
42. Sprague R.S., Olearczyk J.J., Spence D.M., Stephenson A.H., Sprung R.W., Lonigro A.J. Extracellular ATP signaling in the rabbit lung: erythrocytes as determinants of vascular resistance. Am. J. Physiol. 2003, 285:H693-H700.
43. Torres G.E., Haines W.R., Egan T.M., Voigt M.M. Co-expression of P2X1 and P2X5 receptor subunits reveals a novel ATP-gated ion channel. Mol. Pharmacol. 1998, 54:989-993.